Belatacept in Renal Transplantation: Patterns of Use Analysis Using the Collaborative Transplant Study (CTS).
Phase of Trial: Phase IV
Latest Information Update: 09 May 2018
At a glance
- Drugs Belatacept (Primary) ; Calcineurin inhibitors
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 03 May 2018 Status changed from active, no longer recruiting to completed.
- 23 Jun 2014 Planned End Date changed from 1 Feb 2014 to 1 Apr 2018 as reported by ClinicalTrials.gov record.
- 23 Jun 2014 Planned primary completion date changed from 1 Feb 2014 to 1 Apr 2018 as reported by ClinicalTrials.gov record.